Page 55 - TD-3-1
P. 55

Tumor Discovery                                                Mechanism of Buddleja officinalis against ESCC



            2.7. Gene Ontology (GO) and Kyoto Encyclopedia of   target gene networks had 24 nodes and 73 edges, as shown
            Genes and Genomes (KEGG) pathway enrichment        in  Figure  2B. The PPI network files were subsequently
            analysis                                           visualized  by  Cytoscape  3.9.1.  NetworkAnalyzer  utilized
            Initially, the potential target genes were converted to   the “degrees” to highlight the importance of nodes, and
            Entrez IDs using the R package (“org.Hs.eg.db, version =   the top five nodes with high degrees were considered core
            3.8”). Subsequently, GO biological functions and KEGG   targets,  that is, serum albumin (ALB), AKT1, insulin-
            pathway analysis were visualized by the R packages   like growth factor 1 receptor (IGF1), estrogen receptor
            (“DOSE,” “clusterProfiler,” and “Pathview”).       (ESR1), and fibroblast growth factor receptor 1 (FGFR1)
                                                               (Figure 2C and Table 3).
            2.8. Docking for dominant ingredients
                                                               3.3. GO and KEGG analyses
            We investigated the docking of selected active components   To further examine whether the biological functions
            identified from the BO-ESCC PPI network onto the   of the candidates are associated with ESCC, the terms
            receptors of threonine protein kinase (AKT1) using
            AutoDock software. The names, molecular weights, and   subdivided in three distinct ontologies, that is, biological
            three-dimensional structures of BO ingredients were   process (BP), cellular component (CC), and molecular
                                                               function (MF), were enriched in GO and KEGG analyses
            initially acquired from PubChem (https://pubchem.ncbi.  by R programming language. In the BP group (Figure 3A),
            nlm.nih.gov/). Next, the three-dimensional structure of
            ingredients was derived from the RCSB protein data bank   the results suggested that BO might regulate ESCC-
            (http://www.rcsb.org/). Finally, the AutoDock software   related BPs, such as organ growth, gland development,
            was  utilized  to  facilitate  the  preparation  of  ligands  and   and reproductive structure development. Subsequently,
            targets essential for docking. Afterward, for the target   the majority of the GO terms are associated with secretory
            proteins, the water molecules of the crystal structures   granule  lumen, cytoplasmic vesicle lumen, and vesicle
            were removed, hydrogenation was performed, amino   lumen (Figure 3B). In the BP group (Figure 3C), the GO
            acids were modified, energy was optimized, and the force   terms mainly included transmembrane receptor protein
            field parameters were adjusted to satisfy the low-energy   kinase activity, glycosaminoglycan binding, and nuclear
            conformations of the ligand structures. Subsequently,   receptor activity. In addition, 41 signaling pathways
            the AKT1 and key active components were molecularly   were identified through KEGG pathway analysis as
            docked, with the affinity (kcal/mol) value representing   significantly enriched (P < 0.05). Figure 4 displays a bar
            the binding ability between targets and ligands. Finally,   plot  showcasing  the  top  20  important  pathways.  The
            the docking results were observed and analyzed using   signaling pathways that are closely related to ESCC include
            Discovery Studio software.                         MAPK signaling pathway, adhesion junction pathway,
                                                               and gastric cancer pathway. The gastric cancer pathway is
            3. Results                                         closely associated with the MAPK signaling pathway and
                                                               is involved in processes such as activation of oncogenes,
            3.1. Establishment of the BO active ingredients    inactivation  of  tumor  suppressor  genes,  dysregulation
            database                                           of cell cycle control, and impairment of apoptosis in
            Six dominant ingredients of BO were retrieved from the   gastric cancer. In addition, MAPK signaling pathway, the
            TCMSP and HERB databases, including acacetin, linarin,   most relevant signaling pathway according to counting
            luteolin, butyrospermyl acetate, procyanidin B1, and   numbers, is illustrated in Figure 5. The network revealed
            neobyakangelicol (Table 1).                        that BO is associated with the treatment of ESCC through
                                                               multiple targets and multiple pathways. Figure 6 shows
            3.2. Potential targets of BO for inhibiting ESCC and   a compound-target-pathway network centered on the
            visualization of PPI network                       inhibition of ESCC.
            By searching the GeneCard and DisGeNET databases,   3.4. Docking of BO dominant ingredients to AKT1
            a total of 3640 ESCC target genes were generated after
            excluding duplicates. The results of the Venny 2.1 online   The six dominant ingredients of BO can bind to AKT1
            tool showed that 24 shared BO-ESCC targets were    receptor  proteins  to  varying  degrees  as  ligands,  and
            obtained (Figure 2A and Table 2). To further clarify the   the lower vina scores indicate stronger and more stable
            relationships among these overlapping target genes, PPI   binding capacity between ligands and receptors (Table 4).
            network analysis was performed, indicating that these   The vina scores of linarin, procyanidin B1, acacetin,





            Volume 3 Issue 1 (2024)                         4                          https://doi.org/10.36922/td.2312
   50   51   52   53   54   55   56   57   58   59   60